|
Cost-Effectiveness of Recombinant Human TNK Tissue-Type Plasminogen Activator (Rhtnk-Tpa) Versus Recombinant Tissue Plasminogen Activator (Rt-PA) in Treating STElevation Myocardial Infarction (STEMI) | Insight Medical PublishingDennis Xuan,Dunming Xiao,Hongjun Yin,Jianwei Xuan,Qin Yang,Shuiqing ZHU,Yingrui Xu
|